Clinical Trials Browser

vadimezan × Genitourinary × Clear all

NCT01071928 2015-08-19

Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma

Phase 2 Withdrawn

Carcinoma, Transitional Cell

NCT00111618 2009-01-30

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms